Enjoy complimentary customisation on priority with our Enterprise License!
The Rosacea Treatment Market size is forecast to increase by USD 744.29 million, at a CAGR of 6.2% between 2023 and 2028.
There has been an increasing focus on personalized treatment approaches. Personalized treatment approaches play a crucial role in driving the growth of the market. In addition, as the understanding of rosacea has deepened among medical professionals, researchers, and patients, it has become increasingly evident that the condition manifests differently in different people, with varying triggers, symptoms, and treatment responses. Therefore, this recognition has fueled a shift toward personalized treatment strategies tailored to the specific needs of and symptoms in each patient. Hence, such factors are positively impacting the market.
To learn more about this report, Download Report Sample
The hospital pharmacies segment is estimated to witness significant growth during the forecast period. The hospital pharmacies segment plays a major role in providing comprehensive care for rosacea patients, providing a wide range of treatment options that are tailored to individual needs and preferences. In addition, within hospital settings, pharmacists work closely with dermatologists and other healthcare providers to ensure optimal management symptoms as well as complications.
Get a glance at the market contribution of various segments Download PDF Sample
The hospital pharmacies segment was the largest segment and was valued at USD 833.94 million in 2018. Moreover, hospital pharmacies typically stock a variety of topical medications, oral medications, and injectable treatments that are commonly used ensuring that patients have access to the most appropriate therapies for their condition. In addition, topical medications are a cornerstone of , and hospital pharmacies often carry a range of such formulations, including creams, gels, and foams. Furthermore, pharmacists can provide guidance on the selection of the appropriate topical treatment based on factors such as the severity of the disease, skin type, and treatment goals. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Topical medications are a major aspect , providing targeted relief for the characteristic symptoms of the condition, including facial redness, papules, and pustules. In addition, topical treatments for rosacea are typically administered directly to affected skin areas, providing localized action while minimizing other systemic side effects. Moreover, one of the most commonly prescribed topical treatments for rosacea is metronidazole gel or cream, which has anti-inflammatory and antimicrobial properties. Furthermore, Metronidazole helps reduce redness and inflammation associated with rosacea while also targeting the underlying bacteria that contribute to the development of the condition. In addition, another frequently used topical medication is azelaic acid, which exerts anti-inflammatory effects and helps normalize skin cell turnover, thereby reducing the formation of papules and pustules. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Oral medications are mainly prescribed for the treatment of rosacea, especially in cases where topical treatments alone are insufficient to control symptoms or when the condition is severe. In addition, oral medications for rosacea target inflammation, vascular abnormalities, and the underlying pathophysiological processes that contribute to the development of symptoms. Moreover, one of the most widely used oral medications for rosacea is oral antibiotics, such as doxycycline, minocycline, and tetracycline. In addition, these antibiotics possess anti-inflammatory properties and can help reduce inflammation and redness associated with rosacea by targeting bacterial proliferation in the skin. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 46% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The rosacea treatment market in North America has been witnessing significant growth fuelled by the increase in the geriatric population and a high prevalence of chronic and infectious skin diseases, which has raised the demand for rosacea treatment in this region. In addition, growing awareness about diagnostic tests for dermatological conditions among the geriatric population, especially in the US, has increased the demand for rosacea treatment in the country. Moreover, the aging population in North America, especially in the US and Canada, is likely to contribute to the expansion of the market. Furthermore, increasing healthcare expenditure and investments in research and development activities aimed at developing innovative therapies for rosacea are expected to drive market growth in the region during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 18 market companies, including:
Aclaris Therapeutics Inc: The company offers rosacea treatment through HOFADE oxymetazoline hydrochloride topical cream. This is a FDA approved prescription treatment indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The rising awareness of rosacea, characterized by redness and other symptoms, is a pivotal factor propelling market expansion. Increased consciousness and detection of rosacea play significant roles in fostering the global market's growth trajectory. Moreover, notable efforts in public awareness campaigns, educational programs, and media coverage spotlight the often overlooked and underdiagnosed nature of rosacea.
Consequently, more individuals are recognizing the signs and symptoms of rosacea, resulting in heightened patient self-referrals and proactive dialogues with healthcare providers regarding potential diagnoses and treatments. Furthermore, improvements in medical education and training have empowered healthcare professionals, including dermatologists, primary care physicians, and nurse practitioners, to better identify and diagnose rosacea in clinical settings. Hence, these elements drive market growth throughout the forecast period.
Significant Trends
A key factor shaping the market growth is the rising focus on combination therapies. As the understanding of the complex pathophysiology of rosacea increases, it becomes very evident that the condition often involves multiple underlying factors, including inflammation, vascular abnormalities, and microbial dysregulation. As a result, a one-size-fits-all approach to rosacea treatment may not be sufficient to address the diverse and interconnected aspects of the condition effectively.
Moreover, combination therapies offer a multifaceted approach by simultaneously targeting different pathogenic mechanisms underlying the condition. For instance, a combination of topical agents such as antibiotics, azelaic acid, and anti-inflammatory agents can help reduce inflammation, control bacterial overgrowth, and improve skin barrier function, thereby addressing multiple aspects of rosacea pathology in a synergistic manner. Hence, such factors are driving the market growth during the forecast period.
Side effects and safety concerns related are one of the key challenges hindering the market growth. While the different medications and procedures are available to manage rosacea symptoms, they can often be accompanied by severe side effects that impact adherence to treatment, patient satisfaction, and overall market expansion. In addition, topical medications that are commonly prescribed for rosacea, such as antibiotics, azelaic acid, and retinoids, may cause skin irritation, dryness, and hypersensitivity reactions in some individuals.
Moreover, these side effects can be particularly problematic for patients with sensitive skin or underlying dermatological conditions, leading to the discontinuation of treatment or reluctance to start therapy. In addition, oral medications, including antibiotics, isotretinoin, and anti-inflammatory agents, are associated with a range of systemic side effects that may limit their long-term use. Furthermore, antibiotics, for example, can disrupt the normal balance of the gut microbiome, leading to gastrointestinal disturbances and increasing the risk of antibiotic resistance. Hence, such factors are hindering the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
In addressing rosacea, characterized by flushing and visible blood vessels, the treatment market aims to alleviate symptoms and improve quality of life. With rising incidence, public needs prompt efforts to develop efficient interventions that save time. Topical and oral medications, laser therapy, and lifestyle modifications constitute key approaches. Ongoing research ensures innovative solutions, meeting evolving prevalence of rosacea from patient needs and advancing care standards for this prevalent skin disorder.
The market report forecasts market growth by revenue at global, regional & country levels and provides a market research and growth analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028.
Rosacea Treatment Market Scope |
|
Report Coverage |
Details |
Page number |
170 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.2% |
Market Growth 2024-2028 |
USD 744.29 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.75 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 46% |
Key countries |
US, Germany, UK, Russia, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Aclaris Therapeutics Inc., AKUMS, Bausch Health Companies Inc., Croda International Plc, Dermata Therapeutics Inc., Galderma SA, Glenmark Pharmaceuticals Ltd., Hovione, Journey Medical Corp., LEO Pharma AS, Lupin Ltd., Maruho Co. Ltd., Mayne Pharma Group Ltd., Pfizer Inc., PruGen LLC, Sol-Gel Technologies Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Zydus Lifesciences Ltd. |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.